Sign in

CIK 0001790340 · <br>Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 43 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 Bogle Grant C. Director Grant or award · Stock Option +66,700 66,700
2026-07-16 Gengos Andrew Chief Financial Officer Grant or award · Stock Option +650,000 650,000
2026-06-23 Zeskind Benjamin J. PRESIDENT AND CEO Purchase +2,400 $4.56 $11K 2,315,252
2026-06-15 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Purchase +6,035 $4.15 $25K 382,531
2026-06-11 Schall Thomas J. Director Grant or award · Stock Option +33,350 33,350
2026-06-11 HAUSMAN DIANA Director Grant or award · Stock Option +33,350 33,350
2026-06-11 CARPENTER ROBERT J Director Grant or award · Stock Option +33,350 33,350
2026-06-11 KEATING LAURIE Director Grant or award · Stock Option +33,350 33,350
2026-06-11 Feinberg Peter Director Grant or award · Stock Option +33,350 33,350
2026-03-13 Neufeld Leah R CHIEF PEOPLE OFFICER Grant or award +3,628 $4.29 $16K 29,598
2026-02-03 Bookman Michael CHIEF LEGAL OFFICER, SECRETARY Grant or award · Stock Option +176,000 176,000
2026-02-03 Brakewood Harold Eugene Chief Business Officer Grant or award · Stock Option +140,000 140,000
2026-02-03 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option +344,000 344,000
2026-02-03 Matushansky Igor Chief Medical Officer Grant or award · Stock Option +140,000 140,000
2026-02-03 Morales Mallory SVP Finance, CAO Grant or award · Stock Option +140,000 140,000
2026-02-03 Neufeld Leah R CHIEF PEOPLE OFFICER Grant or award · Stock Option +140,000 140,000
2026-02-03 Zeskind Benjamin J. PRESIDENT AND CEO Grant or award · Stock Option +688,000 688,000
2026-01-16 Brakewood Harold Eugene Chief Business Officer Purchase +5,250 $4.76 $25K 11,050
2026-01-15 Schall Thomas J. Director Purchase +21,645 $4.67 $101K 74,530
2026-01-15 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Purchase +2,298 $4.57 $11K 376,496

Page 1 of 8 · 150 trades